Salvianolic acid B exerts vasoprotective effects through the modulation of heme oxygenase-1 and arginase activities

Journal of Pharmacology and Experimental Therapeutics

Volumn 341, Issue 3, 2012, Pages 850-858

  Joe, Yeonsoo ^a   Zheng, Min ^a   Kim, Hyo Jeong ^a   Kim, Sena ^a   Uddin, Md Jamal ^a   Park, Chul ^b   Ryu, Do Gon ^b   Kang, Shin Sung ^a   Ryoo, Sungwoo ^c   Ryter, Stefan W ^d   Chang, Ki Churl ^e   Chung, Hun Taeg ^a  

^a University of Ulsan   (South Korea)

^b Wonkwang University   (South Korea)

^c Kangwon National University   (South Korea)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e Gyeongsang National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROTOPORPHYRIN; REACTIVE OXYGEN METABOLITE; SALVIA MILTIORRHIZA EXTRACT; SALVIANOLIC ACID B; SN PROTOPORPHYRIN IX; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG ACTIVITY; DRUG DETERMINATION; DRUG EFFICACY; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; INFLAMMATION; KIDNEY; LIVER; MACROPHAGE; MALE; MODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT RESPONSE; VASCULAR TISSUE; VASODILATATION; VASOPROTECTIVE ACTIVITY;

ANIMALS; ARGINASE; BENZOFURANS; BLOTTING, WESTERN; DRUGS, CHINESE HERBAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FIBRINOLYTIC AGENTS; HEME OXYGENASE-1; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHENANTHROLINES; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALVIA MILTIORRHIZA; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR DISEASES;

EID: 84861535775     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.111.190736     Document Type: Article

References (40)

1. Berkowitz DE, White R, Li D, Minhas KM, Cernetich A, Kim S, Burke S, Shoukas AA, Nyhan D, Champion HC, et al. (2003) Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 108:2000-2006. (Pubitemid 37296546)
2. Bredt DS and Snyder SH (1994) Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 63:175-195.
3. Chen YH, Du GH, and Zhang JT (2000) Salvianolic acid B protects brain against injuries caused by ischemia-reperfusion in rats. Acta Pharmacol Sin 21:463-466.
4. Cheng TO (2006) Danshen: what every cardiologist should know about this Chinese herbal drug. Int J Cardiol 110:411-412.
5. Collart MA, Baeuerle P, and Vassalli P (1990) Regulation of tumor necrosis factor αtranscription in macrophages: involvement of four κB-like motifs and of constitutive and inducible forms of NF-κB. Mol Cell Biol 10:1498-1506.
6. de Martin R, Vanhove B, Cheng Q, Hofer E, Csizmadia V, Winkler H, and Bach FH (1993) Cytokine-inducible expression in endothelial cells of an IκB α-like gene is regulated by NFκB. EMBO J 12:2773-2779. (Pubitemid 23218326)
7. Du GH, Qiu Y, and Zhang JT (2000) Salvianolic acid B protects the memory functions against transient cerebral ischemia in mice. J Asian Nat Prod Res 2:145-152.
8. Fish JM, Welchons DR, Kim YS, Lee SH, Ho WK, and Antzelevitch C (2006) Dimethyl lithospermate B, an extract of Danshen, suppresses arrhythmogenesis associated with the Brugada syndrome. Circulation 113:1393-1400. (Pubitemid 43739435)
9. Fleming I, Bauersachs J, and Busse R (1997) Calcium-dependent and calcium-independent activation of the endothelial NO synthase. J Vasc Res 34:165-174. (Pubitemid 27281691)
10. Fukuto JM and Chaudhuri G (1995) Inhibition of constitutive and inducible nitric oxide synthase: potential selective inhibition. Annu Rev Pharmacol Toxicol 35:165-194.
11. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, and Sessa WC (1999) Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399:597-601.
12. Garvey EP, Oplinger JA, Tanoury GJ, Sherman PA, Fowler M, Marshall S, Harmon MF, Paith JE, and Furfine ES (1994) Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothioureas. J Biol Chem 269:26669-26676.
13. Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, Di Silvio M, Wang SC, Nakayama DK, Simmons RL, Snyder SH, and Billiar TR (1993) Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci U S A 90:3491-3495. (Pubitemid 23111392)
14. Han JY, Fan JY, Horie Y, Miura S, Cui DH, Ishii H, Hibi T, Tsuneki H, and Kimura I (2008) Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. Pharmacol Ther 117:280-295.
15. Hansson GK and Libby P (2006) The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 6:508-519. (Pubitemid 43980523)
16. Iwashina M, Hirata Y, Imai T, Sato K, and Marumo F (1996) Molecular cloning of endothelial, inducible nitric oxide synthase gene from rat aortic endothelial cell. Eur J Biochem 237:668-673. (Pubitemid 26157655)
17. Jiang RW, Lau KM, Hon PM, Mak TC, Woo KS, and Fung KP (2005) Chemistry and biological activities of caffeic acid derivatives from Salvia miltiorrhiza. Curr Med Chem 12:237-246. (Pubitemid 40089836)
18. Jonasson L, Holm J, Skalli O, Bondjers G, and Hansson GK (1986) Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6:131-138. (Pubitemid 16024121)
19. Kim KM, Pae HO, Zhung M, Ha HY, Ha YA, Chai KY, Cheong YK, Kim JM, and Chung HT (2008) Involvement of anti-inflammatory heme oxygenase-1 in the inhibitory effect of curcumin on the expression of pro-inflammatory inducible nitric oxide synthase in RAW264.7 macrophages. Biomed Pharmacother 62:630-636.
20. Lamas S, Marsden PA, Li GK, Tempst P, and Michel T (1992) Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci U S A 89:6348-6352.
21. Liu CL, Xie LX, Li M, Durairajan SS, Goto S, and Huang JD (2007) Salvianolic acid B inhibits hydrogen peroxide-induced endothelial cell apoptosis through regulating PI3K/Akt signaling. PLoS One 2:e1321.
22. Marczin N, Jilling T, Papapetropoulos A, Go C, and Catravas JD (1996) Cytoskeleton-dependent activation of the inducible nitric oxide synthase in cultured aortic smooth muscle cells. Br J Pharmacol 118:1085-1094. (Pubitemid 26235605)
23. Moncada S, Palmer RM, and Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142.
24. Nathan C (1997) Inducible nitric oxide synthase: what difference does it make? J Clin Invest 100:2417-2423.
25. Nathan C and Xie QW (1994) Regulation of biosynthesis of nitric oxide. J Biol Chem 269:13725-13728. (Pubitemid 24191108)
26. Oh GS, Pae HO, Choi BM, Chae SC, Lee HS, Ryu DG, and Chung HT (2004) 3-Hydroxyanthranilic acid, one of metabolites of tryptophan via indoleamine 2,3- dioxygenase pathway, suppresses inducible nitric oxide synthase expression by enhancing heme oxygenase-1 expression. Biochem Biophys Res Commun 320:1156-1162.
27. Oh GS, Pae HO, Lee BS, Kim BN, Kim JM, Kim HR, Jeon SB, Jeon WK, Chae HJ, and Chung HT (2006) Hydrogen sulfide inhibits nitric oxide production and nuclear factor-κB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Radic Biol Med 41:106-119. (Pubitemid 43884782)
28. Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, Davis RJ, Flavell RA, and Choi AM (2000) Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6:422-428. (Pubitemid 30208159)
29. Pae HO, Jeong SO, Jeong GS, Kim KM, Kim HS, Kim SA, Kim YC, Kang SD, Kim BN, and Chung HT (2007) Curcumin induces pro-apoptotic endoplasmic reticulum stress in human leukemia HL-60 cells. Biochem Biophys Res Commun 353:1040-1045. (Pubitemid 46080402)
30. Santhanam L, Lim HK, Lim HK, Miriel V, Brown T, Patel M, Balanson S, Ryoo S, Anderson M, Irani K, et al. (2007) Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction. Circ Res 101:692-702. (Pubitemid 47494100)
31. Shultz PJ, Archer SL, and Rosenberg ME (1994) Inducible nitric oxide synthase mRNA and activity in glomerular mesangial cells. Kidney Int 46:683-689. (Pubitemid 24272024)
32. Steppan J, Ryoo S, Schuleri KH, Gregg C, Hasan RK, White AR, Bugaj LJ, Khan M, Santhanam L, Nyhan D, et al. (2006) Arginase modulates myocardial contractility by a nitric oxide synthase 1-dependent mechanism. Proc Natl Acad Sci U S A 103:4759-4764.
33. Stuehr DJ and Marletta MA (1985) Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci U S A 82:7738-7742. (Pubitemid 16204424)
34. Tang MK, Ren DC, Zhang JT, and Du GH (2002) Effect of salvianolic acids from Radix Salviae miltiorrhizae on regional cerebral blood flow and platelet aggregation in rats. Phytomedicine 9:405-409.
35. Wang Y and Marsden PA (1995) Nitric oxide synthases: biochemical and molecular regulation. Curr Opin Nephrol Hypertens 4:12-22.
36. Watzke A, O'Malley SJ, Bergman RG, and Ellman JA (2006) Reassignment of the configuration of salvianolic acid B and establishment of its identity with lithospermic acid B. J Nat Prod 69:1231-1233. (Pubitemid 44409804)
37. White AR, Ryoo S, Li D, Champion HC, Steppan J, Wang D, Nyhan D, Shoukas AA, Hare JM, and Berkowitz DE (2006) Knockdown of arginase I restores NO signaling in the vasculature of old rats. Hypertension 47:245-251. (Pubitemid 43189770)
38. Woo A, Min B and Ryoo S (2010) Piceatannol-3′-O-β-D- glucopyranoside as an active component of rhubarb activates endothelial nitric oxide synthase through inhibition of arginase activity. Exp Mol Med 42:524-532.
39. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, and Nathan C (1992) Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256:225-228.
40. Zhou L, Zuo Z, and Chow MS (2005) Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 45:1345-1359. (Pubitemid 41643896)